The Biomarkers Task Force initiative was made possible by the following individuals:
Steering Committee
Lisa H. Butterfield, PhD University of Pittsburgh Cancer Institute
|
Mary L. Disis, MD University of Washington
|
Bernard A. Fox, PhD Earle A. Chiles Research Institute
|
Samir N. Khleif, MD Georgia Health Sciences
|
Francesco Marincola, MD Sidra Medical and Research Center
|
Jon M. Wigginton, MD Bristol-Myers Squibb Company
|
FDA Liaisons
Raj K. Puri, MD, PhD
FDA, CBER
Ashok Batra, MD
FDA, CBER
Working Group 1 - Biomarker Validation and Application
Co-Chairs
Lisa H. Butterfield, PhD
University of Pittsburgh Cancer Institute
Mary L. Disis, MD
University of Washington
A. Karolina Palucka, MD, PhD
Baylor Institute for Immunology Research
Members
Madhav Dhodapkar, MD Yale University
|
Sylvia Janetzki, MD ZellNet Consulting, Inc.
|
Thomas O. Kleen, PhD Epiontis GmbH
|
Cristina Maccalli, PhD Foundation San Raffaele Foundation Scientific Institute
|
Holden T. Maecker, PhD Stanford University Medical Center |
Anatoli M. Malyguine, MD, PhD SAIC-Frederick, Inc.
|
Giuseppe V. Masucci, MD, PhD Karolinska University Hospital, Solna
|
Douglas M. Potter, PhD University of Pittsburgh
|
Licia Rivoltini, MD Instituto Nazionale dei Tumori
|
Craig L. Slingluff, MD University of Virginia
|
David Stroncek, MD National Institutes of Health
|
Theresa L. Whiteside, PhD University of Pittsburgh Cancer Institute
|
Heinz Zwierzina, MD Medizinishe Universitat Innsbruck
|
|
|
Working Group 2 - Novel Assays for Immunotherapy Clinical Trials
Co-Chairs
Franco Marincola, MD
Sidra Medical and Research Center
Peter P. Lee, MD
Stanford University
Members
Damien Chaussabel, PhD Baylor Institute for Immunology Research
|
George Coukos, MD, PhD University of Pennsylvania Medical Center
|
Bernard A. Fox, PhD Earle A. Chiles Research Institute
|
|
John M. Kirkwood, MD University of Pittsburgh
|
Leif Hakansson, MD, PhD Biotherapy Development Association
|
Michele Maio, MD, PhD Azienda Ospedalieria Senese
|
|
Antoni Ribas, MD University of California Los Angeles Medical Center
|
Dolores J. Schendel, PhD Helmholtz Zentrum Munchen
|
Barbara Selinger, PhD Institute of Medical Immunology, Martin Luther University
|
|
Senthamil R. Selvan, PhD Thomas Jefferson University
|
Wenru Song, MD, PhD Millennium: The Takeda Oncology Company
|
Howard Streicher, MD National Cancer Institute - CTEP
|
|
Magdalena Thurin, PhD National Cancer Institute
|
Giorgio Trinchieri, MD National Cancer Institute
|
Ena Wang, MD National Institutes of Health
|
|
Xifeng Wu, MD, PhD MD Anderson Cancer Center
|
Benjamin J. Zeskind, PhD, MBA Immuneering Corporation
|
Yingdong Zhao, PhD National Cancer Institute
|
|